![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
More and more clinical studies are taking place in Russia, making it an attractive market for medical writing. In 2011, the Ministry of Healthcare of the Russian Federation approved over 550 new clinical studies of all types, a 16% increase over the previous year. Currently, the Russian government is making huge investments in its infrastructure for drug development. Demand for medical writing is high in the rapidly growing sector of biotechnology in Russia. Because there are some differences in local requirements compared to the EU or USA, many specific regulatory aspects have to be considered by medical writers in Russia.
Additional information
Notes on contributors
Anna Davydova
Anna Davydova is a business development manager at OCT, a full-service contract research organisation operating in Russia, Ukraine, Bulgaria, Belarus, Latvia, Lithuania, Estonia. Anna started her industrial career at a global contract research organisation in 2007. After several successful years in clinical operations, she joined the OCT business development team.